WHO ICTRP trial
Neoadjuvant trial of pre-operative exemestane or letrozole +/- celecoxib in the…
ISRCTN09768535 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN09768535 |
|---|---|
| Public title | Neoadjuvant trial of pre-operative exemestane or letrozole +/- celecoxib in the treatment of oestrogen receptor-positive early breast cancer |
| Scientific title | Neoadjuvant trial of pre-operative exemestane or letrozole +/- celecoxib in the treatment of oestrogen receptor-positive early breast cancer |
| Primary sponsor | University Hospital Birmingham NHS Foundation Trust (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | Scotland;United Kingdom;England |
| Conditions | Early breast cancer Cancer Breast cancer |
| Interventions | Subjects will be randomised (1:1:1:1) to receive either: 1. Exemestane + celecoxib (these patients will receive exemestane 25 mg, one tablet daily and celecoxib 400 mg, one tablet twice daily) 2. Exemestane + celecoxib-placebo (these… |
| Registration date | Nov 7, 2006 |
| Target size | 256 |
| Secondary IDs | BR3031 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: